Collection of Blood to Evaluate Epigenomics and Protein Biomarkers for the Detection of Hepatocellular Carcinoma

Sponsor:

Helio Health, Inc.

Sponsor Study ID:

HELIO-2021-US-002

CTO #:

103649

NCT Number:

NCT05199259

Phase:

N/A

Protocol Type:

Other

Age Group:

Adults

Disease Sites:

Liver

Study Objectives:

The objective of this study is the acquisition of whole blood samples and serum samples from subjects with untreated HCC and subjects undergoing HCC surveillance. These samples will be used for research purposes to develop and validate the Helio multi-analyte blood test.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)